Sequence comparison of the V/P and F genes of 13 human, canine, porcine and simian isolates of simian virus 5 (SV5) revealed a surprising lack of sequence variation at both the nucleotide and amino acid levels (0–3 %), even though the viruses were isolated over 30 years and originated from countries around the world. Furthermore, there were no clear distinguishing amino acid or nucleotide differences among the isolates that correlated completely with the species from which they were isolated. In addition, there was no evidence that the ability of the viruses to block interferon signalling by targeting STAT1 for degradation was confined to the species from which they were isolated. All isolates had an extended cytoplasmic tail in the F protein, compared with the original W3A and WR monkey isolates. Sequence analysis of viruses that were derived from human bone-marrow cells isolated in London in the 1980s revealed that, whilst they were related more closely to one another than to the other isolates, they all had identifying differences, suggesting that they were independent isolates. These results therefore support previous data suggesting that SV5 can infect humans persistently, although the relationship of SV5 to any human disease remains highly contentious. Given that SV5 has been isolated on multiple occasions from different species, it is proposed that the term simian virus 5 is inappropriate and suggested that the virus should be renamed parainfluenza virus 5.
AndrejevaJ.,
YoungD. F.,
GoodbournS.,
RandallR. E.2002; Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J Virol 76:2159–2167[CrossRef]
AtoynatanT.,
HsiungG. D.1969; Epidemiologic studies of latent virus infections in captive monkeys and baboons. II. Serologic evidence of myxovirus infections with special reference to SV5. Am J Epidemiol 89:472–479
BasleM. F.,
RussellW. C.,
GoswamiK. K. A.,
RebelA.,
GiraudonP.,
WildF.,
FilmonR.1985; Paramyxovirus antigens in osteoclasts from Paget's bone tissue detected by monoclonal antibodies. J Gen Virol 66:2103–2110[CrossRef]
BaumgärtnerW. K.,
MetzlerA. E.,
KrakowkaS.,
KoestnerA.1981; In vitro identification and characterization of a virus isolated from a dog with neurological dysfunction. Infect Immun 31:1177–1183
BaumgärtnerW. K.,
KrakowkaS.,
KoestnerA.,
EvermannJ.1982; Acute encephalitis and hydrocephalus in dogs caused by canine parainfluenza virus. Vet Pathol 19:79–92[CrossRef]
BaumgärtnerW.,
KrakowkaS.,
BlakesleeJ.1987a; Evolution of in vitro persistence of two strains of canine parainfluenza virus. Brief report. Arch Virol 93:147–154[CrossRef]
BaumgärtnerW.,
KrakowkaS.,
BlakesleeJ. R.1987b; Persistent infection of Vero cells by paramyxoviruses. A morphological and immunoelectron microscopic investigation. Intervirology 27:218–223[CrossRef]
BaumgärtnerW.,
KrakowkaS.,
DurchfeldB.1991; In vitro cytopathogenicity and in vivo virulence of two strains of canine parainfluenza virus. Vet Pathol 28:324–331[CrossRef]
BironC. A.,
SenG. C.2001; Interferons and other cytokines. In Fields Virology , 4th edn. pp 321–349 Edited by
FieldsB. N.,
KnipeD. M.,
HowleyP. M.
Philadelphia, PA: Lippincott-Raven;
ChanockR. M.,
JohnsonK. M.,
CookM. K.,
WongD. C.,
VargoskoA.1961; The hemadsorption technique with a special reference to the problem of naturally occurring simian parainfluenza viruses. Am Rev Respir Dis 83:125–129
ChatziandreouN.,
YoungD.,
AndrejevaJ.,
GoodbournS.,
RandallR. E.2002; Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for virus persistence. Virology 293:234–242[CrossRef]
CornwellH. J.,
McCandlishI. A.,
ThompsonH.,
LairdH. M.,
WrightN. G.1976; Isolation of parainfluenza virus SV5 from dogs with respiratory disease. Vet Rec 98:301–302[CrossRef]
DidcockL.,
YoungD. F.,
GoodbournS.,
RandallR. E.1999b; The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 73:9928–9933
EvermannJ. F.,
LincolnJ. D.,
McKiernanA. J.1980; Isolation of a paramyxovirus from the cerebrospinal fluid of a dog with posterior paresis. J Am Vet Med Assoc 177:1132–1134
GoswamiK. K. A.,
RandallR. E.,
LangeL. S.,
RussellW. C.1987; Antibodies against the paramyxovirus SV5 in the cerebrospinal fluids of some multiple sclerosis patients. Nature 327:244–247[CrossRef]
HeB.,
LinG. Y.,
DurbinJ. E.,
DurbinR. K.,
LambR. A.2001; The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J Virol 75:4068–4079[CrossRef]
HeB.,
PatersonR. G.,
StockN.,
DurbinJ. E.,
DurbinR. K.,
GoodbournS.,
RandallR. E.,
LambR. A.2002; Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon- β induction and interferon signaling. Virology 303:15–32[CrossRef]
HeinenE.,
HerbstW.,
SchmeerN.1998; Isolation of a cytopathogenic virus from a case of porcine reproductive and respiratory syndrome (PRRS) and its characterization as parainfluenza virus type 2. Arch Virol 143:2233–2239[CrossRef]
Horta-BarbosaL.,
FuccilloD. A.,
HamiltonR.,
TraubR.,
LeyA.,
SeverJ. L.1970; Some characteristics of SSPE measles virus. Proc Soc Exp Biol Med 134:17–21[CrossRef]
HuddlestoneJ. R.,
SipeJ.,
BrahenyS.,
JensenF. C.,
McMillanR.,
LampertP.,
OldstoneM. B. A.1979; Failure to isolate a transmissible agent from the bone-marrow of patients with multiple sclerosis. Lancet ii 415:
HuelsenbeckJ. P.,
RonquistF.,
NielsenR.,
BollbackJ. P.2001; Bayesian inference of phylogeny and its impact on evolutionary biology. Science 294:2310–2314[CrossRef]
HullR. N.,
MinnerJ. R.,
SmithJ. W.1956; New viral agents recovered from tissue cultures of monkey cells. I. Origin and properties of cytopathogenic agents SV1, SV2, SV4, SV5, SV6, SV11, SV12 and SV15. Am J Hyg 63:204–215
ItoM.,
NishioM.,
KawanoM.,
KusagawaS.,
KomadaH.,
ItoY.,
TsurudomeM.1997; Role of a single amino acid at the amino terminus of the simian virus 5 F2 subunit in syncytium formation. J Virol 71:9855–9858
ItoM.,
NishioM.,
KomadaH.,
ItoY.,
TsurudomeM.2000; An amino acid in the heptad repeat 1 domain is important for the haemagglutinin–neuraminidase-independent fusing activity of simian virus 5 fusion protein. J Gen Virol 81:719–727
LambR. A.,
KolakofskyD.2001; Paramyxoviridae : the viruses and their replication. In Fields Virology, 4th edn. pp 1305–1340 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia, PA: Lippincott-Raven;
LevyD. E.,
García-SastreA.2001; The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 12:143–156[CrossRef]
LiebhaberH.,
KrugmanS.,
McGregorD.,
GilesJ. P.1965; Studies of a myxovirus recovered from patients with infectious hepatitis. I. Isolation and characterization. J Exp Med 122:1135–1150[CrossRef]
LimC. S.,
ChanK. P.,
GohK. T.,
ChowV. T. K.2003; Hemagglutinin-neuraminidase sequence and phylogenetic analyses of mumps virus isolates from a vaccinated population in Singapore. J Med Virol 70:287–292[CrossRef]
McLeanB. N.,
ThompsonE. J.1989; Antibodies against the paramyxovirus SV5 are not specific for cerebrospinal fluid from multiple sclerosis patients. J Neurol Sci 92:261–266[CrossRef]
ParisienJ.-P.,
LauJ. F.,
HorvathC. M.2002; STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J Virol 76:6435–6441[CrossRef]
ParkM.-S.,
García-SastreA.,
CrosJ. F.,
BaslerC. F.,
PaleseP.2003; Newcastle disease virus V protein is a determinant of host range restriction. J Virol 77:9522–9532[CrossRef]
PatersonR. G.,
HarrisT. J. R.,
LambR. A.1984; Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A 81:6706–6710[CrossRef]
PooleE.,
HeB.,
LambR. A.,
RandallR. E.,
GoodbournS.2002; The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon- β
. Virology 303:33–46[CrossRef]
RandallR. E.,
YoungD. F.1988; Comparison between parainfluenza virus type 2 and simian virus 5: monoclonal antibodies reveal major antigenic differences. J Gen Virol 69:2051–2060[CrossRef]
RandallR. E.,
RussellW. C.1991; Paramyxovirus persistence: consequences for host and virus. In The Paramyxoviruses pp 299–321 Edited by
KingsburyD. W.
New York: Plenum;
RandallR. E.,
BerminghamA.1996; NP : P and NP : V interactions of the paramyxovirus simian virus 5 examined using a novel protein : protein capture assay. Virology 224:121–129[CrossRef]
RandallR. E.,
YoungD. F.,
GoswamiK. K. A.,
RussellW. C.1987; Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. J Gen Virol 68:2769–2780[CrossRef]
RimaB. K.,
EarleJ. A. P.,
BaczkoK.7 other authors1997; Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol 78:97–106
RosenbergF. J.,
LiefF. S.,
ToddJ. D.,
ReifJ. S.1971; Studies of canine respiratory viruses. I. Experimental infection of dogs with an SV5-like canine parainfluenza agent. Am J Epidemiol 94:147–165
SakaguchiT.,
ToyodaT.,
GotohB.,
InocencioN. M.,
KumaK.,
MiyataT.,
NagaiY.1989; Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology 169:260–272[CrossRef]
SethS.,
VincentA.,
CompansR. W.2003; Mutations in the cytoplasmic domain of a paramyxovirus fusion glycoprotein rescue syncytium formation and eliminate the hemagglutinin-neuraminidase protein requirement for membrane fusion. J Virol 77:167–178[CrossRef]
SouthernJ. A.,
YoungD. F.,
HeaneyF.,
BaumgärtnerW. K.,
RandallR. E.1991; Identification of an epitope on the P and V proteins of simian virus 5 that distinguishes between two isolates with different biological characteristics. J Gen Virol 72:1551–1557[CrossRef]
ThomasS. M.,
LambR. A.,
PatersonR. G.1988; Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 54:891–902[CrossRef]
TongS.,
LiM.,
VincentA.,
CompansR. W.,
FritschE.,
BeierR.,
KlenkC.,
OhuchiM.,
KlenkH.-D.2002; Regulation of fusion activity by the cytoplasmic domain of a paramyxovirus F protein. Virology 301:322–333[CrossRef]
TsurudomeM.,
NishioM.,
KomadaH.,
BandoH.,
ItoY.1989; Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies. Virology 171:38–48[CrossRef]
UlaneC. M.,
HorvathC. M.2002; Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 304:160–166[CrossRef]
van Wyke CoelinghK. L.,
WinterC. C.,
MurphyB. R.1988; Nucleotide and deduced amino acid sequence of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957 to 1983. Virology 162:137–143[CrossRef]
WallenW. C.,
SeverJ. L.,
McFarlinD. E.,
McFarlandH. F.,
TraubR. G.,
RentierB.,
GreensteinJ. I.,
MooreP. M.1979; Attempt to isolate infectious agent from bone-marrow of patients with multiple sclerosis. Lancet ii:414–415
WansleyE. K.,
ParksG. D.2002; Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death. J Virol 76:10109–10121[CrossRef]
YoungD. F.,
RandallR. E.,
HoyleJ. A.,
SouberbielleB. E.1990; Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody. J Virol 64:5403–5411